Deficits in axonal transport are thought to contribute to the pathology of many neurodegenerative diseases. Expressing the slow Wallerian degeneration protein (Wld S ) or related nicotinamide mononucleotide adenyltransferases (NmNATs) protects axons against damage from a broad range of insults, but the ability of these proteins to protect against inhibition of axonal transport has received little attention. We set out to determine whether these proteins can protect the axons of cultured hippocampal neurons from damage due to hydrogen peroxide or oxygen-glucose deprivation (OGD) and, in particular, whether they can reduce the damage that these agents cause to the axonal transport machinery. Exposure to these insults inhibited the axonal transport of both mitochondria and of the vesicles that carry axonal membrane proteins; this inhibition occurred hours before the first signs of axonal degeneration. Expressing a cytoplasmically targeted version of NmNAT1 (cytNmNAT1) protected the axons against both insults. It also reduced the inhibition of transport when cells were exposed to hydrogen peroxide and enhanced the recovery of transport following both insults. The protective effects of cytNmNAT1 depend on mitochondrial transport. When mitochondrial transport was inhibited, cytNmNAT1 was unable to protect axons against either insult. The protective effects of mitochondrially targeted NmNAT also were blocked by inhibiting mitochondrial transport. These results establish that NmNAT robustly protects the axonal transport system following exposure to OGD and reactive oxygen species and may offer similar protection in other disease models. Understanding how NmNAT protects the axonal transport system may lead to new strategies for neuroprotection in neurodegenerative diseases.
Introduction
The unique geometry of neurons makes them particularly vulnerable to injuries that disrupt the microtubule-based transport of organelles between the cell body and the distal axon. Not surprisingly, genetic mutations that affect components of the axonal transport system, such as kinesins and dynein, lead to diseases that are characterized by axonal degeneration (Blackstone et al., 2011; Holzbaur and Scherer, 2011) . Deficits in axonal transport may also contribute to the axonal degeneration that occurs following insults such as inflammation (Fang et al., 2012a; Stagi et al., 2005; Takeuchi et al., 2005) and are thought to contribute to the pathology in many neurodegenerative diseases (Bilsland et al., 2010; Decker et al., 2010; Her and Goldstein, 2008) . Studies of cultured neurons show that inhibition of axonal transport is among the earliest signs of damage following exposure to reactive oxygen species or other insults (Fang et al., 2012a; Stagi et al., 2005) . Thus there is a strong motivation to identify agents that can protect against damage to the axonal transport machinery.
The Wallerian degeneration slow (Wld S ) mutation, which arose spontaneously in a line of C57Black mice, greatly prolongs the survival of axons that have been cut off from their cell bodies (Coleman et al., 1998) . The mutation leads to the expression of a chimeric protein that is a fusion of the first 70 amino acids from Ube4b, an E4 ubiquitin ligase, and the full length sequence of nicotinamide mononucleotide adenyltransferase 1 (NmNAT1), one of three isoforms of the adenylating enzyme responsible for the biosynthesis of NAD + (Coleman, 2005 
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